Publications:

---

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.

Nature Communications

Gounder, Mrinal M MM; Agaram, Narasimhan P NP; Trabucco, Sally E SE; Robinson, Victoria V; Ferraro, Richard A RA; Millis, Sherri Z SZ; Krishnan, Anita A; Lee, Jessica J; Attia, Steven S; Abida, Wassim W; Drilon, Alexander A; Chi, Ping P; Angelo, Sandra P D' SP; Dickson, Mark A MA; Keohan, Mary Lou ML; Kelly, Ciara M CM; Agulnik, Mark M; Chawla, Sant P SP; Choy, Edwin E; Chugh, Rashmi R; Meyer, Christian F CF; Myer, Parvathi A PA; Moore, Jessica L JL; Okimoto, Ross A RA; Pollock, Raphael E RE; Ravi, Vinod V; Singh, Arun S AS; Somaiah, Neeta N; Wagner, Andrew J AJ; Healey, John H JH; Frampton, Garrett M GM; Venstrom, Jeffrey M JM; Ross, Jeffrey S JS; Ladanyi, Marc M; Singer, Samuel S; Brennan, Murray F MF; Schwartz, Gary K GK; Lazar, Alexander J AJ; Thomas, David M DM; Maki, Robert G RG; Tap, William D WD; Ali, Siraj M SM; Jin, Dexter X DX

Publication Date: 2022-06-15

Variant appearance in text: NF1: C383*

PubMed Link: 35705558

Variant Present in the following documents:

• 41467_2022_30496_MOESM2_ESM.xls, sheet 1

View BVdb publication page

---

Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.

Nature Communications

Anastasaki, Corina C; Mo, Juan J; Chen, Ji-Kang JK; Chatterjee, Jit J; Pan, Yuan Y; Scheaffer, Suzanne M SM; Cobb, Olivia O; Monje, Michelle M; Le, Lu Q LQ; Gutmann, David H DH

Publication Date: 2022-05-19

Variant appearance in text: NF1: Cys383X

PubMed Link: 35589737

Variant Present in the following documents:

• 41467_2022_Article_30466.pdf
• 41467_2022_30466_MOESM1_ESM.pdf

View BVdb publication page

---

Patient-derived iPSC-cerebral organoid modeling of the 17q11.2 microdeletion syndrome establishes CRLF3 as a critical regulator of neurogenesis.

Cell Reports

Wegscheid, Michelle L ML; Anastasaki, Corina C; Hartigan, Kelly A KA; Cobb, Olivia M OM; Papke, Jason B JB; Traber, Jennifer N JN; Morris, Stephanie M SM; Gutmann, David H DH

Publication Date: 2021-07-06

Variant appearance in text: NF1: 1149C>A

PubMed Link: 34233200

Variant Present in the following documents:

• Main text
• NIHMS1722138-supplement-2.pdf
• nihms-1722138.pdf
• NIHMS1722138-supplement-1.pdf

View BVdb publication page

---

Brain tumors in Neurofibromatosis type 1.

Neuro-Oncology Advances

Costa, Amanda De Andrade AA; Gutmann, David H DH

Publication Date: 2019

Variant appearance in text: NF1: Cys383X

PubMed Link: 32642668

Variant Present in the following documents:

• Main text
• vdz040.pdf

View BVdb publication page

---

Human iPSC-Derived Neurons and Cerebral Organoids Establish Differential Effects of Germline NF1 Gene Mutations.

Stem Cell Reports

Anastasaki, Corina C; Wegscheid, Michelle L ML; Hartigan, Kelly K; Papke, Jason B JB; Kopp, Nathan D ND; Chen, Jiayang J; Cobb, Olivia O; Dougherty, Joseph D JD; Gutmann, David H DH

Publication Date: 2020-04-14

Variant appearance in text: NF1: 1149C>A

PubMed Link: 32243842

Variant Present in the following documents:

• Main text
• mmc2.pdf
• main.pdf

View BVdb publication page

---

Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia.

Neuro-Oncology

Guo, Xiaofan X; Pan, Yuan Y; Gutmann, David H DH

Publication Date: 2019-10-09

Variant appearance in text: NF1: 1149C>A; Cys383X

PubMed Link: 31111915

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Children with 5'-end NF1 gene mutations are more likely to have glioma.

Neurology. Genetics

Anastasaki, Corina C; Morris, Stephanie M SM; Gao, Feng F; Gutmann, David H DH

Publication Date: 2017-10

Variant appearance in text: NF1: 1149C>A; Cys383X

PubMed Link: 28955729

Variant Present in the following documents:

• supp_3.5.e192_NG_2017_005934R1_Supplementary_Data.pdf

View BVdb publication page

---